-
公开(公告)号：AU2003254711A1
公开(公告)日：2003-11-13
申请号：AU2003254711
申请日：2003-10-14
Applicant: ABBOTT LAB
Inventor： ALLEN KIMBERLY A , BAUER PHILIP E , SPIWEK HARRY O , PATEL KETAN , CHEMBURKAR SANJAY R , NARAYANAN BIKSHANDARKOIL A , SALEKI-GERHARDT AZITA , BAUER JOHN F
IPC: C07D417/00
-
公开(公告)号：CZ2001203A3
公开(公告)日：2001-05-16
申请号：CZ2001203
申请日：1999-07-19
Applicant: ABBOTT LAB
Inventor： SPIWEK HARRY O , BAUER PHILIP E , ALLEN KIMBERLEY A
IPC: A61K31/426 , A61K31/427 , A61P31/18 , A61P37/04 , C07D277/24 , C07D277/28 , C07D277/30 , C07D277/36 , C07D277/40 , C07D277/42 , C07D417/12
Abstract: This Application concerns the use of Form II crystalline ritonavir as a pharmaceutical agent, as well as methods of preparing pharmaceutical compositions, which methods employ Form II crystalline ritonavir. The Application further concerns methods for obtaining Form I crystalline ritonavir, which methods employ Form II crystalline ritonavir.
-
公开(公告)号：NO20010298L
公开(公告)日：2001-01-18
申请号：NO20010298
申请日：2001-01-18
Applicant: ABBOTT LAB
Inventor： BAUER JOHN F , SALEKI-GERHARDT AZITA , NARAYANAN BIKSHANDARKOIL A , CHEMBURKAR SANJAY R , PATEL KETAN , SPIWEK HARRY O , BAUER PHILIP E , ALLEN KIMBERLY A
IPC: A61K31/426 , A61K31/427 , A61P31/18 , A61P37/04 , C07D277/24 , C07D277/28 , C07D277/30 , C07D277/36 , C07D277/40 , C07D277/42 , C07D417/12 , C07D417/00
Abstract: This Application concerns the use of Form II crystalline ritonavir as a pharmaceutical agent, as well as methods of preparing pharmaceutical compositions, which methods employ Form II crystalline ritonavir. The Application further concerns methods for obtaining Form I crystalline ritonavir, which methods employ Form II crystalline ritonavir.
-
公开(公告)号：MY145265A
公开(公告)日：2012-01-13
申请号：MYPI0402546
申请日：1999-07-16
Applicant: ABBOTT LAB
Inventor： BAUER JOHN F , SALEKI-GERHARDT AZITA , NARAYANAN BIKSHANDARKOR A , CHEMBURKAR SANJAY R , PATEL KETAN M , SPIWEK HARRY O , BAUER PHILIP E , ALLEN KIMBERLY A
IPC: A61K31/426 , A61K31/427 , A61P31/18 , A61P37/04 , C07D277/24 , C07D277/28 , C07D277/30 , C07D277/36 , C07D277/40 , C07D277/42 , C07D417/12
Abstract: SUBSTANTIALLY PURE AMORPHOUS RITONAVIR IS DISCLOSED. ALSO DISCLOSED A PROCESS FOR THE PREPARATION OF SUBSTANTIALLY PURE RITANOVIR CRYSTALLINE POLYMORPH FORM I COMPRISING ADDING A SOLUTION OF RITONAVIR TO A SLURRY OF SEED CRYSTALS OF RITONAVIR CRYSTALLINE POLYMORPH FORM I IN AN ANTI-SOLVENT.
-
25.发明专利
公开(公告)号：PT2017269E
公开(公告)日：2011-12-20
申请号：PT08007622
申请日：1999-07-19
Applicant: ABBOTT LAB
Inventor： BAUER JOHN F , PATEL KETAN , SPIWEK HARRY O , CHEMBURKAR SANJAY R , SALEKI-GERHARDT AZITA
IPC: C07D277/24 , A61K31/425 , A61K31/426 , A61K31/427 , A61P31/18 , A61P37/04 , C07D277/28 , C07D277/30 , C07D277/36 , C07D277/40 , C07D277/42 , C07D417/12
-
Patent Agency Ranking26.发明专利
公开(公告)号：HK1121155A1
公开(公告)日：2009-04-17
申请号：HK09100857
申请日：2009-01-29
Applicant: ABBOTT LAB
Inventor： BAUER JOHN F , SALEKI-GERHARDT AZITA , CHEMBURKAR SANJAY R , PATEL KETAN , SPIWEK HARRY O
IPC: A61K20060101 , A61K31/426 , A61K31/427 , A61P31/18 , A61P37/04 , C07D20060101 , C07D277/24 , C07D277/28 , C07D277/30 , C07D277/36 , C07D277/40 , C07D277/42 , C07D417/12
Abstract: This Application concerns the use of Form II crystalline ritonavir as a pharmaceutical agent, as well as methods of preparing pharmaceutical compositions, which methods employ Form II crystalline ritonavir. The Application further concerns methods for obtaining Form I crystalline ritonavir, which methods employ Form II crystalline ritonavir.
-
公开(公告)号：SK286388B6
公开(公告)日：2008-09-05
申请号：SK922001
申请日：1999-07-19
Applicant: ABBOTT LAB
Inventor： BAUER JOHN F , SALEKI-GERHARDT AZITA , NARAYANAN BIKSHANDARKOIL A , CHEMBURKAR SANJAY R , PATEL KETAN , SPIWEK HARRY O , BAUER PHILIP E , ALLEN KIMBERLY A
IPC: A61K31/00 , A61K31/426 , A61K31/427 , A61P31/00 , A61P31/18 , A61P37/00 , A61P37/04 , C07D277/00 , C07D277/24 , C07D277/28 , C07D277/30 , C07D277/36 , C07D277/40 , C07D277/42 , C07D417/00 , C07D417/12
Abstract: Described is a crystalline polymorph of ritonavir and methods for its use and preparation.
-
公开(公告)号：PL194710B1
公开(公告)日：2007-06-29
申请号：PL34803399
申请日：1999-07-19
Applicant: ABBOTT LAB
Inventor： BAUER JOHN F , SALEKI-GERHARDT AZITA , NARAYANAN BIKSHANDARKOIL A , CHEMBURKAR SANJAY R , PATEL KETAN , SPIWEK HARRY O , BAUER PHILIP E , ALLEN KIMBERLY A
IPC: C07D277/24 , A61K31/425 , A61K31/426 , A61K31/427 , A61P31/18 , A61P37/04 , C07D277/28 , C07D277/30 , C07D277/36 , C07D277/40 , C07D277/42 , C07D417/12
Abstract: This Application concerns the use of Form II crystalline ritonavir as a pharmaceutical agent, as well as methods of preparing pharmaceutical compositions, which methods employ Form II crystalline ritonavir. The Application further concerns methods for obtaining Form I crystalline ritonavir, which methods employ Form II crystalline ritonavir.
-
公开(公告)号：HK1057040A1
公开(公告)日：2004-03-12
申请号：HK03107574
申请日：2003-10-17
Applicant: ABBOTT LAB
Inventor： CHEMBURKAR SANJAY R , PATEL KETAN M , SPIWEK HARRY O
IPC: C07D20060101 , C07B53/00 , C07D239/10 , C07D403/06 , C07D521/00
Abstract: The instant invention provides processes and intermediates employed in the synthesis of ((2S,3S,5S)-2-(2,6-dimethylphenoxyacetyl)-amino-3-hydroxy-5-(2S-(1-tetrahydropyrimid-2-onyl)-3-methyl-butanoyl)amino-1,6-diphenylhexane and analogs thereof.
-
公开(公告)号：AU768207B2
公开(公告)日：2003-12-04
申请号：AU5003799
申请日：1999-07-19
Applicant: ABBOTT LAB
Inventor： BAUER JOHN F , SALEKI-GERHARDT AZITA , NARAYANAN BIKSHANDARKOIL A , CHEMBURKAR SANJAY R , PATEL KETAN , SPIWEK HARRY O , BAUER PHILIP E , ALLEN KIMBERLY A
IPC: A61K31/426 , A61K31/427 , A61P31/18 , A61P37/04 , C07D277/24 , C07D277/28 , C07D277/30 , C07D277/36 , C07D277/40 , C07D277/42 , C07D417/12 , C07D417/00
Abstract: This Application concerns the use of Form II crystalline ritonavir as a pharmaceutical agent, as well as methods of preparing pharmaceutical compositions, which methods employ Form II crystalline ritonavir. The Application further concerns methods for obtaining Form I crystalline ritonavir, which methods employ Form II crystalline ritonavir.
-
-
-
-
-
-
-
-
-
Search Results
67
records
(took 0.023 seconds)
